Status:
COMPLETED
Personalized Nudging to Increase Influenza Vaccinations
Lead Sponsor:
Geisinger Clinic
Collaborating Sponsors:
Massachusetts Institute of Technology
University of Michigan
Conditions:
Influenza, Human
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to prospectively test whether personalized, message-based nudges can increase flu vaccination compared with nudges that are not personalized or no nudges.
Detailed Description
On average, 8% of the US population gets sick from influenza each flu season. Since 2010, the annual disease burden of influenza in the U.S. has included 9-41 million illnesses, 140,000-710,000 hospit...
Eligibility Criteria
Inclusion
- Age 18+
- Has not received the 2024 flu vaccine according to the Geisinger electronic health record (EHR) prior to randomization
- Has a non-acute, flu-shot eligible, in-person Geisinger appointment scheduled with enough time to be randomized
- Has a Geisinger primary care provider
Exclusion
- Cannot be contacted by SMS (e.g., due to insufficient/missing contact information in the EHR or because they opted out)
- Appointment type or department not approved for outreach by Geisinger leadership at the time of outreach
- Has an allergy to flu vaccines according to any EHR allergy table known to the study team
- Has a health maintenance modifier indicating they are permanently discontinued from receiving a seasonal flu shot
- Shares a phone number with someone who has already been enrolled
Key Trial Info
Start Date :
September 9 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
77482 Patients enrolled
Trial Details
Trial ID
NCT06566534
Start Date
September 9 2024
End Date
December 31 2024
Last Update
January 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger Clinic
Danville, Pennsylvania, United States, 17822